Company Description
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States.
It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services.
It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.
The company was incorporated in 2015 and is headquartered in Santa Monica, California.
| Country | United States |
| IPO Date | Sep 23, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 694 |
| CEO | Wendy Barnes |
Contact Details
Address: 2701 Olympic Boulevard Santa Monica, California United States | |
| Website | https://www.goodrx.com |
Stock Details
| Ticker Symbol | GDRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001809519 |
| CUSIP Number | 38246G108 |
| ISIN Number | US38246G1085 |
| Employer ID | 47-5104396 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Wendy Barnes | Chief Executive Officer |
| Karsten Ian Voermann | Chief Financial Officer |
| Nitin Shingate | Chief Technology Officer |
| Aubrey Reynolds | Director of Investor Relations |
| Bansi Nagji | President of Healthcare |
| Douglas Joseph Hirsch | Co-founder & Director |
| Gracye Cheng | Senior Vice President, General Counsel & Secretary |
| Romin Nabiey | Chief Accounting Officer |
| Scott W. Wagner | Principal Operating Officer |
| Trevor Bezdek | Co-founder & Chairman of the Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Jan 08, 2025 | 4 | Filing |
| Jan 08, 2025 | 3 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Dec 23, 2024 | 4 | Filing |
| Dec 18, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 18, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 16, 2024 | 8-K | Current Report |
| Dec 09, 2024 | 4 | Filing |